Skip to main content

Propel Bio Management, LLC

13F filer · CIK 0001969764
Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$191MU.S. long equity reported on 13F
Positions293 new · 12 closed
Net flow last quarter-$7.61MBuys minus sells
Top 10 positions weight68.1%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 202629 positions
PAGPPlains GP Holdings LP$30.9M16.16%0.64%Not reportedQ4 2023
ACHVAchieve Life Sciences, Inc.$26.3M13.79%3.93%+6.5%Q1 2024
CORTCorcept Therapeutics Inc$11.9M6.21%0.13%-7.7%Q1 2026
PHATPhathom Pharmaceuticals, Inc.$11.4M5.96%1.31%+24.9%Q4 2023
DCTHDelcath Systems, Inc.$11M5.74%2.52%-11.1%Q4 2024
MISTMilestone Pharmaceuticals Inc.$9.96M5.21%5.97%+80.4%Q1 2025
CMPSCOMPASS Pathways plc$8.11M4.24%0.42%-22.8%Q3 2024
KYTXKyverna Therapeutics, Inc.$7.87M4.12%1.43%+37.1%Q4 2025
ARTVArtiva Biotherapeutics, Inc.$6.76M3.54%2.82%+375.8%Q1 2026
ABEOAbeona Therapeutics Inc.$6.08M3.18%1.72%-26.1%Q2 2024
AQSTAquestive Therapeutics, Inc.$6M3.14%1.15%+102.9%Q1 2026
PALIPalisade Bio, Inc.$5.4M2.82%1.49%+131.6%Q1 2026
IMUXImmunic, Inc.$5M2.61%2.38%+38.6%Q1 2026
IVAInventiva S.A.$4.84M2.53%0.66%+76.8%Q4 2025
SABSSAB Biotherapeutics, Inc.$4.2M2.20%1.29%+6.3%Q4 2025
OBIOOrchestra BioMed Holdings, Inc.$3.87M2.02%1.49%Not reportedQ1 2026
CLDXCelldex Therapeutics, Inc.$3.86M2.02%0.13%-21.1%Q3 2025
ZVRAZevra Therapeutics, Inc.$3.64M1.90%0.43%-10.2%Q3 2024
OCULOcular Therapeutix, Inc$3.52M1.84%0.16%-6.4%Q1 2026
FDMT4D Molecular Therapeutics, Inc.$3.36M1.76%0.46%-33.6%Q1 2026
OVIDOvid Therapeutics Inc.$3M1.57%0.60%+21.1%Q1 2026
EYPTEyePoint, Inc.$2.74M1.43%0.23%-11.2%Q1 2026
UPBUpstream Bio, Inc.$2.42M1.27%0.64%+2.5%Q1 2026
SCYXScynexis Inc$2.21M1.16%5.46%NewQ2 2026
SLNSilence Therapeutics plc$2.11M1.10%0.14%NewQ2 2026
LONALeonaBio, Inc.$1.37M0.72%1.58%Not reportedQ3 2025
MAZEMaze Therapeutics, Inc.$1.31M0.68%0.08%Not reportedQ1 2026
CRVSCorvus Pharmaceuticals, Inc.$1.05M0.55%0.08%-18.0%Q1 2026
SGMTSagimet Biosciences Inc.$973K0.51%0.41%NewQ2 2026
Q1 2026Reported May 14, 202638 positions
PAGPPlains GP Holdings LP$30.2M19.02%0.64%Not reportedQ4 2023
ACHVAchieve Life Sciences, Inc.$11.4M7.17%7.11%Not reportedQ1 2024
PHATPhathom Pharmaceuticals, Inc.$9.35M5.90%1.06%+13.5%Q4 2023
DCTHDelcath Systems, Inc.$9.16M5.77%2.84%+123.4%Q4 2024
CORTCorcept Therapeutics Inc$6.02M3.80%0.14%NewQ1 2026
ABEOAbeona Therapeutics Inc.$6.01M3.79%2.34%+60.1%Q2 2024
VORVor Biopharma Inc.$5.59M3.52%0.58%NewQ1 2026
KYTXKyverna Therapeutics, Inc.$5.59M3.52%1.06%-3.3%Q4 2025
MISTMilestone Pharmaceuticals Inc.$5.08M3.20%3.50%Not reportedQ1 2025
CLDXCelldex Therapeutics, Inc.$4.14M2.61%0.20%-14.9%Q3 2025
CMPSCOMPASS Pathways plc$4.12M2.60%0.55%-13.9%Q3 2024
VRDNViridian Therapeutics, Inc.\DE$4.09M2.58%0.21%-25.6%Q3 2025
IVAInventiva S.A.$3.99M2.52%0.38%-27.5%Q4 2025
SABSSAB Biotherapeutics, Inc.$3.89M2.45%1.34%+55.1%Q4 2025
OBIOOrchestra BioMed Holdings, Inc.$3.83M2.41%1.53%NewQ1 2026
FDMT4D Molecular Therapeutics, Inc.$3.58M2.26%0.73%NewQ1 2026
OCSOculis Holding AG$3.28M2.07%Not reported-29.3%Q4 2025
OCULOcular Therapeutix, Inc$3.23M2.03%0.17%NewQ1 2026
UPBUpstream Bio, Inc.$3.1M1.95%0.63%NewQ1 2026
AQSTAquestive Therapeutics, Inc.$2.95M1.86%0.57%NewQ1 2026
EYPTEyePoint, Inc.$2.79M1.76%0.26%NewQ1 2026
TRVITrevi Therapeutics, Inc.$2.65M1.67%0.17%Not reportedQ1 2024
ZVRAZevra Therapeutics, Inc.$2.64M1.66%0.48%+343.5%Q3 2024
IMUXImmunic, Inc.$2.62M1.65%17.21%NewQ1 2026
CHRSCoherus Oncology, Inc.$2.41M1.52%0.92%NewQ1 2026
OVIDOvid Therapeutics Inc.$2.04M1.28%0.55%NewQ1 2026
PALIPalisade Bio, Inc.$2M1.26%0.67%NewQ1 2026
KLRSKalaris Therapeutics, Inc.$1.72M1.08%1.29%+603.3%Q4 2025
QUREuniQure N.V.$1.71M1.08%0.17%NewQ1 2026
LONALeonaBio, Inc.$1.5M0.94%1.59%Not reportedQ3 2025
NUVBNuvation Bio Inc.$1.41M0.89%0.10%NewQ1 2026
MAZEMaze Therapeutics, Inc.$1.31M0.82%0.09%NewQ1 2026
EVMNEvommune, Inc.$1.28M0.81%0.15%NewQ1 2026
CRVSCorvus Pharmaceuticals, Inc.$1.25M0.79%0.10%NewQ1 2026
ALDXAldeyra Therapeutics, Inc.$1.23M0.78%1.21%NewQ1 2026
ARTVArtiva Biotherapeutics, Inc.$950K0.60%0.59%NewQ1 2026
CNTBConnect Biopharma Holdings Ltd$554K0.35%0.33%NewQ1 2026
MSLESatellos Bioscience Inc.$57.1K0.04%0.79%NewQ1 2026
Q4 2025Reported Feb 11, 202620 positions
PAGPPlains GP Holdings LP$24.4M20.79%0.64%Not reportedQ4 2023
ACHVAchieve Life Sciences, Inc.$18.8M16.07%7.11%Not reportedQ1 2024
PHATPhathom Pharmaceuticals, Inc.$12.3M10.49%1.04%+34.0%Q4 2023
VRDNViridian Therapeutics, Inc.\DE$8.79M7.51%0.28%+213.9%Q3 2025
MISTMilestone Pharmaceuticals Inc.$8.32M7.10%3.88%-19.6%Q1 2025
KYTXKyverna Therapeutics, Inc.$6.27M5.35%1.10%NewQ4 2025
CMPSCOMPASS Pathways plc$5.95M5.08%0.90%+69.0%Q3 2024
IVAInventiva S.A.$4.65M3.97%0.52%NewQ4 2025
DCTHDelcath Systems, Inc.$4.43M3.78%1.26%Not reportedQ4 2024
ABEOAbeona Therapeutics Inc.$4.38M3.74%1.51%-14.7%Q2 2024
CLDXCelldex Therapeutics, Inc.$4.19M3.58%0.23%-0.5%Q3 2025
NKTRNektar Therapeutics$3.5M2.99%0.41%+69.0%Q3 2025
OCSOculis Holding AG$3.45M2.95%Not reportedNewQ4 2025
SABSSAB Biotherapeutics, Inc.$2.44M2.08%1.37%NewQ4 2025
RGNXREGENXBIO Inc.$1.68M1.44%0.23%NewQ4 2025
LONALeonaBio, Inc.$1.13M0.96%1.60%Not reportedQ3 2025
LENZLENZ Therapeutics, Inc.$945K0.81%0.19%NewQ4 2025
AARDAardvark Therapeutics, Inc.$609K0.52%0.21%NewQ4 2025
ZVRAZevra Therapeutics, Inc.$571K0.49%0.11%-72.5%Q3 2024
KLRSKalaris Therapeutics, Inc.$355K0.30%0.18%NewQ4 2025
Q3 2025Reported Nov 12, 202516 positions
PAGPPlains GP Holdings LP$23.2M23.23%0.64%Not reportedQ4 2023
ACHVAchieve Life Sciences, Inc.$11.9M11.94%7.17%-38.5%Q1 2024
AKROAkero Therapeutics, Inc.$10.9M10.88%0.29%Not reportedQ4 2023
MISTMilestone Pharmaceuticals Inc.$10.2M10.26%6.02%+186.1%Q1 2025
APLTApplied Therapeutics, Inc.$6.83M6.83%7.82%Not reportedQ4 2023
PHATPhathom Pharmaceuticals, Inc.$6.51M6.51%0.78%-40.1%Q4 2023
ABEOAbeona Therapeutics Inc.$5.14M5.15%1.86%Not reportedQ2 2024
DCTHDelcath Systems, Inc.$4.71M4.72%1.24%+94.0%Q4 2024
CLDXCelldex Therapeutics, Inc.$4.01M4.01%0.23%NewQ3 2025
TCRXTScan Therapeutics, Inc.$3.52M3.52%8.06%-7.4%Q4 2023
CMPSCOMPASS Pathways plc$2.92M2.93%0.53%Not reportedQ3 2024
NKTRNektar Therapeutics$2.79M2.79%0.25%NewQ3 2025
JSPRJasper Therapeutics, Inc.$2.45M2.45%3.68%Not reportedQ4 2024
ZVRAZevra Therapeutics, Inc.$2.21M2.21%0.41%Not reportedQ3 2024
VRDNViridian Therapeutics, Inc.\DE$1.94M1.94%0.11%NewQ3 2025
LONALeonaBio, Inc.$618K0.62%3.79%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.